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Clostridium botulinum in honey: prevalence and antibiotic susceptibility of isolated strains
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Abstract: Clostridium botulinum and rare strains of C. butyricum and C. baratii produce an extremely potent toxin, the botulinum
neurotoxin (BoNT). Infant botulism is significant for both its high mortality rates and for the sophisticated treatment that it requires.
Isolation and identification of C. botulinum according to standards depend on mouse bioassays to determine toxin-producing ability of
strains. Polymerase chain reaction (PCR) is used to detect the types of toxins expressed by bacteria. Since honey is an important source
of infant botulism, we determined the types of toxins secreted by C. botulinum strains and their antibiotic resistance. In this study, the
first step was conducted to determine the prevalence of C. botulinum in different honey types; as the second step, antibiotic susceptibility
of the strains was determined; and, finally, PCR typing of toxin genes was done. Nineteen strains were isolated from 250 honey samples.
All C. botulinum strains were evaluated for BoNT types using PCR. BoNT type A was observed in 12 of the 19 (63.15%) strains, type B
was observed in 3 (15.78%) strains, type F was recorded in 2 (10.52%) strains, and 2 of the 19 (10.52%) strains showed no amplification.
All strains represented a resistance to amoxicillin and trimethoprim sulfamethoxazole (100%), followed with sulfamethoxazole and
ampicillin (94.73%). Resistance to nalidixic acid was seen in 84.21%. The results show that different types of honey are contaminated
with C. botulinum and toxin types also show different distribution. Additionally, antibiotic resistance patterns of the strains showed
different distributions, which indicates obligatory application of antibiotic resistance testing for prevention of secondary infections.
Key words: Clostridium botulinum, honey, PCR

1. Introduction
Food-borne botulism is a severe type of food poisoning
caused by ingesting foods containing the potent botulinum
neurotoxin (BoNT), formed during microorganism growth.
Clostridium botulinum and its spores are found in soil, in
dust, and on surfaces (1). Infant botulism is a severe but
transient neuroparalytic disease that affects infants under
1 year of age. Paralysis is caused by the action of BoNTs
that block the release of neurotransmitter acetylcholine
from motor endings of all peripheral cholinergic synapses.
BoNTs are produced in vivo by Clostridium botulinum
and other BoNT-producing clostridia that temporarily
colonize the intestinal tract of infants (2).
Honey, syrup, and foods with high viscosity have been
identified as potential sources of infection (3), while dust
and honey have been shown to be sources of spores (2,4).
There was also an exceptional case that occurred due to
turkey consumption by 8-month-old baby girl in Italy (5).
Honey has been identified both as a dietary risk factor for
infant botulism and as a natural reservoir of C. botulinum
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type A and B spores (1). Immature infantile intestinal
flora allows ingested spores to germinate, multiply,
and produce botulinum neurotoxins in the intestinal
lumen. Children aged between 2 weeks and 1 year are
most susceptible (6). The main clinical features of infant
botulism are constipation, hypotonia, listlessness, lethargy,
difficulty in suckling and swallowing, weak crying, pooled
oral secretions, general muscle weakness, and loss of
head control. Infantile botulism management includes
prevention of nosocomial complications, antitoxin
administration, and supportive therapy. Antibiotics
against C. botulinum are not used in infantile botulism.
Antibiotics cause microorganisms to die and decompose,
which leads to a leak of intracytoplasmic toxins into the
intestinal lumen, thus causing severe results (7). Secondary
infections should be treated with antibiotics that do not have
bactericidal effects on C. botulinum (e.g., trimethoprimsulfamethoxazole or amoxicillin clavulanate). It is known
that aminoglycoside antibiotics have synergetic effects on
toxin binding to the neuromuscular plate.
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The results of different studies, which have been
conducted in different countries with different types of
honey, indicate that honey can be contaminated with C.
botulinum (8–13).
According to German Institute for Standardization
(Deutsches Institut für Normung, DIN) standards,
the isolation and identification of C. botulinum takes
approximately 12 days (14). Toxinotyping can be performed
with mouse bioassays. However, many researchers ignore
this method for ethical reasons. In the second half of
the 20th century, studies on the ethics of experimental
animals gained interest and ethical codes relating to animal
experimentation came into force. Several alternative
methods that could be used instead of animal experiments
were developed, with many organizations across the
world working in this field. Both these “alternative
methods” and ethical concerns, which brought about
the assumption of responsibility for laboratory animals,
constituted the basis of the principles adopted by national
and international organizations operating in the area of
animal experimentation, as well as the basis of relevant
legislation enacted (15–18). The Turkish Food Codex
Honey Communiqué, published in the Official Journal on
17 December 2005 with the number of 26026 (19), clearly
stipulated zero tolerance for the presence of C. botulinum
and other food-borne pathogenic bacteria, eggs of parasites,
and adult parasites. To meet the legal requirements, good
manufacturing practices are applied by honey producers.
The aim of this study was to determine the prevalence
of C. botulinum in different types of honey. Since
antibiotic administration is discouraged in infant botulism
management and it is recommended only for treatment
of secondary infections, we also investigated antibiotic
resistance of the strains.
2. Materials and methods
A total of 250 honey samples were obtained from different
markets in Ankara. The distribution of honeys was: 150
extracted honeys (117 were in original packaging and
33 were sold openly) and 100 comb honeys (39 were in
original packaging and 61 were sold openly). All honey
samples were collected from December 2007 to May 2008.
2.1. Methods
Isolation and identification was performed according to
DIN 10102 (14), which is shown in the Figure.
2.1.1. Identification of toxin types of C. botulinum strains
The method indicated for toxin typing in the DIN 10102
procedure includes mouse bioassays. Due to animal
welfare reasons, we preferred to apply the polymerase chain
reaction (PCR) method reported by de Medici et al. with
some modifications. The PCR primers are given in Table
1. In this study, no internal control primer was used (20).

For the PCR reaction, a 50-µL reaction mixture
containing 2X multiplex PCR master mixture, 0.3 µM of
each primer (Table 1), and 3 µL of purified DNA template
was used. The reaction mixture was heated at 95 °C for 15
min to activate the Taq polymerase and then subjected to
35 cycles of denaturation at 95 °C for 30 s, annealing at 56
°C for 30 s, and extension at 72 °C for 90 s, followed by a
final extension at 72 °C for 7 min.
2.1.2. Antibiotic resistance of C. botulinum strains
C. botulinum isolates from honey were submitted to
antibiotic susceptibility testing with the following
molecules: sulfamethoxazole (25 µg), trimethoprim/
sulfamethoxazole (1:19) (co-trimoxazole) (25 µg),
nalidixic acid (30 µg), gentamicin (30 µg), penicillin G (5
units), tetracycline (30 µg), ampicillin (25 µg), amoxicillin
(25 µg), and cefalotin (30 µg). All strains were spread on
Mueller Hinton agar (Oxoid, UK) dishes, and disks were
applied to the surface and incubated at 37 °C for 24 h.
All dishes were evaluated for zones and the results were
recorded. Dishes were incubated at 37 °C for an additional
24 h. The zones were checked and changes noted.
3. Results
In this study, 250 honey samples were analyzed to detect
C. botulinum. C. botulinum was isolated and identified
from 19 (7.6%) honey samples. All strains were typical
in the microscopic evaluation. Biochemical identification
showed a distribution of 19 C. botulinum strains, 12 strains
of C. butyricum, and 1 strain of C. noyvi. Two strains’
colony morphologies were atypical on anaerobic egg yolk
(AEY) agar plates; one strain was isolated from comb
honey and the other from extracted honey. Some strains
gave weak or no turbidity at 7 days, but strong turbidity on
day 10 of incubation. The 2 strains giving atypical colonies
were taken from AEY and restreaked on AEY again when
typical colonies were observed. All strains were grampositive and spore-forming.
All C. botulinum strains were typed using PCR. BoNT
type A was observed in 12 of the 19 (63.15%) strains,
type B in 3 of the 19 (15.78%) strains, and type F in 2
(10.52%) strains, while 2 of the 19 (10.52%) strains showed
no amplification. The 2 amplification-negative strains
were extracted again and the test was repeated, but they
again showed no BoNT amplification. The isolation and
identification results are given in Table 2.
3.1. Antibiotic susceptibility
Table 3 shows the results of antibiotic susceptibility
analysis. All strains were tested for resistance against
several antibiotics and the results are given in Table 3.
4. Discussion
Several studies are reported in the world literature on
the prevalence of C. botulinum in honey. Midura et al.
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40 g honey +
40 mL gel phosphate buffer

Homogenize in stomacher

C. botulinum detection

Freeze for toxin analysis

2g homogenate + Cooked
Meat Medium
Close with 5 mL vaspar
Incubate 5 days, anaerobic
No visible bacterial growth
Additional 5 days of incubation
No growth
Discard
Turbidity
AEY agar inoculation

Turbidity, gas
AEY Agar inoculation
Gram staining

2g homogenate + TPGYT
broth

Close with 5 mL vaspar.
Incubate 5 days, anaerobic
No visible bacterial growth
Additional 5 days of incubation
No growth
Discard
Turbidity, gas, proteolysis of
meat pieces

Turbidity

AEY agar inoculation
Gram staining

Figure. Isolation and identification scheme according to DIN 10102.

reported C. botulinum in 9 out of 90 honey samples, 6 of
which were isolated from honeys given to infants who
developed botulism (8). Nevas reported the prevalence of
C. botulinum in the 448 extracted honey samples studied
as 12%. Moreover, the overall prevalence of C. botulinum
was 24% in comb honey samples (n = 256) in this study
(12). In studies of 92 French (21,22), 282 German (23,24),
and 134 Norwegian (25) honey samples, no C. botulinum
spores were detected. In 2 different studies held in
Argentina, Centorbi et al. isolated C. botulinum from 1 out
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of 42 honey samples (26) and Monetto et al. reported 2
positive samples out of 44 honey samples (27). Different
studies held in the United States showed C. botulinum
in 10 out of 80, 2 out of 100, and 18 out of 241 honey
samples (28–30). In a study held in Italy, C. botulinum
was isolated from 2 among 39 honey samples (31). In
Turkey, C. botulinum contamination was reported in 6
out of 48 honey samples (11). The results of some of the
authors above are consistent with those of our study. On
the other hand, differences between results of our study
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Table 1. Primers and product sizes for toxinotyping of C. botulinum strains.
Toxin type
A
B
E
F

Primer name

Product size (bp)

IOA (Forward)

GGG CCT AGA GGT AGC GTA CTG

IOA (Reverse)

TCT TAA TTT CCA GAA GCA TAT TTT

CBMLB (Forward)

CAG GAG AAG TGG AGC GAA AA

CBMLB (Reverse)

CTT GCG CCT TTG TTT TCT TG

CBMLE (Forward)

CCA AGA TTT TCA TCC GCC TA

CBMLE (Reverse)

GCT ATT GAT CCA AAA CGG TGA

CBMLF (Forward)

CGG CTT CAT TAG AGA ACG GA

CBMLF (Reverse)

TAA CTC CCC TAG CCC CGT AT

101
205
389
543

Table 2. The isolation and identification results obtained from this study.

No.

Type of honey
EH (P)

TPGY incubation
7 days

10 days

+

+

AEY

Gram

+

+

Toxin type
A

EH (O)

+

+

+

+

+

+

+

+

+

+

CH (O)

+

+

+

+

+

CH (P)

+

+

+

+

+

EH (P)

+

+

+

+

+

CH (O)

+

+

+

+

+

+

AT

+

EH (O)

-

+

+

+

EH (O)

+

+

+

+

EH (P)

+

+

+

+

EH (O)

+

+

+

+

+
+
+
+

+

+

AT

+

+

+

+

+

+

+
+

+

+

+

+

+

+

+

+

EH (P)

-

+

+

+

EH (O)

+

+

+

+

EH (O)

+

+

+

+

NAM

+

CH (P)
EH (P)

F

+

CH (O)
CH(O)

E

+

CH (P)

EH (P)

B

+
+
+
+

EH: Extracted honey, CH: comb honey, (O): sold openly, (P): in its original packaging, NAM: no
amplification, AT: atypical, TPGY: trypticase peptone yeast extract broth, AEY: anaerobe egg yolk agar.

and those of others may be due to sampling, enrichment,
and incubation. The study by Küplülü et al. showed that
results obtained with different enrichment methods are
statistically important (11).
In a study by Nevas, 61 of 256 comb honey samples
were found to be contaminated with C. botulinum. These
61 strains showed toxin type distribution as follows: type

A in 3 strains, type B in 54 strains, type E in 3 strains, and
type F in 1. The authors also analyzed 448 extracted honey
samples and reported contamination in 53 samples. These
53 strains showed toxin-type distribution as follows: 17
type-A, 40 type-B, and 5 type-E strains (12). The results
are consistent with ours and the distribution of toxin types
show parallelism with our results.
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Table 3. Antibiotic susceptibility test results. R: Resistant, I: intermediate, S: susceptible.
Antibiotic

Concentration

R

I

S

Sulfamethoxazole
Trimethoprim/sulfamethoxazole
(1:19) (co-trimoxazole)
Nalidixic Acid

25 µg

18/19

1/19

-

25 µg

19/19

-

-

30 µg

16/19

2/19

1/19

Gentamicin

30 µg

5/19

3/19

11/19

Penicillin G

5 units

4/19

9/19

6/19

Tetracycline

30 µg

6/19

4/19

9/19

Ampicillin

25 µg

18/19

1/19

-

Amoxycillin

25 µg

19/19

-

-

Cefalotin

30 µg

8/19

8/19

3/19

There are limited data about the antibiotic
susceptibility of C. botulinum strains because the use of
antibiotic drugs is discouraged in food-borne and infant
botulism management. Antibiotics are administered only
for treatment of secondary infections, considering that
these drugs could not cause a worsening of neurological
symptomatology (27–30).
There are limited data about the antibiotic resistance
of C. botulinum strains. In a study by Swenson et al.,
susceptibility to tetracycline and penicillin was recorded.
In the same study, C. botulinum strains were reported to
be resistant to cefalotin, trimethoprim-sulfamethoxazole,
nalidixic acid, and gentamicin (30). The data of our study
are in accordance with this study. Resistance can be caused
by application of antibiotics to prevent diseases during
beekeeping. It was reported that 1714 honey samples
were collected from beekeepers from 22 different regions
in Turkey. The samples were analyzed for residues of
sulfonamides, tetracyclines, and streptomycin-group
antibiotics, which are not legally permitted to be used for
beekeeping in Turkey. Enzyme-linked immunosorbent
assay and high-performance liquid chromatographic
techniques were used to analyze the compounds and the
results showed that 10% to 15% of the beekeepers were still
using these antibiotics against foulbrood diseases (28). In
similar studies, antibiotic residues in honeys were found
(28–30). All 19 strains isolated in our study represented
resistance to sulfonamides. This may be caused by the
illegal use of sulfonamides during beekeeping.
Nevas reported that the supernatant filtration method
combined with PCR enables a sensitive, rapid, and
ethically acceptable means of screening honey samples for
the presence of C. botulinum spores (12). PCR is also used
as an alternative method to animal models in scientific
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research. The fact that PCR results are accepted as more
sensitive, specific, and rapid (12) complies with the
ethical criteria required for toxin investigations in which
animal models should be avoided. It was reported with
different gene sequences for detecting C. botulinum (12).
The results of that study indicated that the appropriate
BoNT genes were detected in material from 7 out of the
8 cases of botulism and provided a supportive diagnosis
faster than the conventional bioassay. These assays have
already proven useful for public health microbiological
investigations of suspected cases of human botulism by
substantially improving the diagnostic process.
In conclusion, honey is known to be linked to infant
botulism. There are various routes of honey contamination
with C. botulinum spores. Our results show that beekeepers
should stop the preventative application of antibiotics,
which triggers antibiotic resistance in microorganisms
found in honey. Using irradiation to eliminate C.
botulinum contamination of honey is not acceptable due
to significant changes in the sensory quality of honey.
Good production practices should be applied in honey
production. Public health and food safety concerns of C.
botulinum should be taken into account, especially with
regard to infant botulism. Turkish regulations are strict
about C. botulinum in honey, underlining zero tolerance
and obligatory labeling of honey. This kind of restriction is
significant only for infant botulism because C. botulinum
spores do not represent a risk for adults or young people.
To this aim, in Turkey, like in the United States and in
several European countries, honey labels report that the
product is not recommended for an infant under 1 year
of age. This may lead to an increased awareness, but more
information to pediatricians and honey producers should
be given to improve the overall quality of honey.
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